Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Summary
This phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.
Official title: Intensity-Modulated Stereotactic Radiotherapy as an Upfront Scalp-Sparing Intervention for the Treatment of Newly Diagnosed Grade II-IV Gliomas
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2017-07-17
Completion Date
2027-12-31
Last Updated
2026-01-27
Healthy Volunteers
No
Interventions
Intensity-Modulated Radiation Therapy
Undergo IM-SRT
Quality-of-Life
Ancillary studies
Locations (1)
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States